Oncology Nursing: Chemotherapy Administration

Administering chemotherapy is a high-stakes, complex nursing responsibility that demands precision, vigilance, and deep clinical knowledge. You are not just following an order; you are the final safeguard in a process that delivers potent, often toxic, agents to vulnerable patients. Mastering this role requires an integrated understanding of pharmacology, oncology, patient education, and emergency response to ensure both therapeutic efficacy and patient safety.

Preparation and Safe Handling Protocols

Before a single drop of medication is drawn, meticulous preparation is paramount. Safe handling protocols are non-negotiable procedures designed to protect you, other healthcare workers, and the environment from exposure to cytotoxic agents. This always involves using personal protective equipment (PPE)—including a disposable gown, double gloves (with the outer glove being chemo-rated), and eye protection—within a designated preparation area, often a biological safety cabinet.

Your first clinical action is verifying the treatment plan. This is a multi-step validation process. You must confirm the patient’s identity using two identifiers, check recent laboratory values (especially absolute neutrophil count, platelets, and renal/hepatic function), and reconcile the prescribed regimen against a reliable source, such as the clinic’s standardized protocol or the original oncologist’s note. This verification includes the drug name, dose (often calculated by body surface area), route, rate of infusion, and pre-medications. Any discrepancy must be resolved with the prescribing physician before proceeding.

Venous Access and Administration Techniques

Selecting and managing appropriate venous access is critical. For vesicant drugs (those that cause severe tissue damage) or prolonged regimens, a central venous access device like a PICC line, port-a-cath, or tunneled catheter is standard. For peripheral administration, you must select a large, patent vein in the forearm, avoiding joints, areas of compromise, or limbs with lymphedema. The IV must be patent and show a positive blood return before and during the infusion.

During administration, two of your primary monitoring priorities are anaphylaxis and extravasation. Anaphylaxis is a life-threatening, systemic hypersensitivity reaction. You must monitor closely during the first 15 minutes of any new agent’s infusion, watching for symptoms like urticaria, wheezing, hypotension, and facial edema. Emergency equipment, including epinephrine, must be immediately accessible. Extravasation is the inadvertent leakage of a vesicant drug into the surrounding tissue. You must know the vesicant potential of every drug you administer. Signs include pain, burning, swelling, and redness at the site. If extravasation is suspected, you stop the infusion immediately, aspirate any residual drug from the line, and initiate the specific antidote protocol per institutional policy (e.g., warm or cool compresses, hyaluronidase for vinca alkaloids).

Monitoring and Managing Systemic Toxicities

Chemotherapy’s effects are systemic, and your ongoing assessment targets its predictable toxicities. Myelosuppression, the suppression of bone marrow function, leads to neutropenia, anemia, and thrombocytopenia. You assess for this by tracking daily lab results and monitoring for clinical signs: fever or infection (neutropenia), fatigue and pallor (anemia), and petechiae or bleeding (thrombocytopenia).

Managing nausea with antiemetic regimens is a cornerstone of supportive care. Modern protocols use a multi-drug approach, often combining a 5-HT3 receptor antagonist (like ondansetron), an NK-1 receptor antagonist (like aprepitant), and dexamethasone, administered prophylactically before chemotherapy begins. You must understand the emetogenic potential of the regimen and assess the effectiveness of the antiemetics, providing rescue medications as needed.

Patient Education and Protective Strategies

Your role extends beyond the infusion chair. Educating patients about neutropenic precautions is essential for discharge planning. This includes meticulous hand hygiene, avoiding crowds and sick contacts, thorough cooking of foods, and prompt reporting of a fever of $100.4^{\circ }\text{F}$ ($38^{\circ }\text{C}$) or higher. You also teach them to monitor for signs of infection or bleeding.

These teachings are part of broader infection prevention strategies during immunocompromised periods. You reinforce these strategies during every encounter. Furthermore, in the inpatient setting, you implement protective isolation protocols as ordered, which may include placing the patient in a private room and ensuring all staff and visitors adhere to strict hand hygiene.

Common Pitfalls

1. Rushing the Verification Process: In a busy clinic, there is temptation to streamline the order check. Correction: Treat the verification as a sacred, uninterrupted ritual. Use a systematic checklist every single time. A single decimal error in dose can be fatal.

1. Underestimating Early Complication Signs: Dismissing a patient’s complaint of "a little stinging" at the IV site or a mild itch during an infusion. Correction: Treat any new, subjective complaint as a potential red flag. Pause the infusion and assess thoroughly. Early intervention for extravasation or an allergic reaction drastically improves outcomes.

1. Incomplete Patient Education: Providing education in a rushed, information-dense manner at discharge. Correction: Use teach-back methods. Have the patient explain neutropenic precautions back to you. Provide written, easy-to-read materials and a clear point of contact for questions.

1. Focusing Solely on Physical Tasks: Becoming so task-oriented with the pump and lines that you neglect therapeutic communication and holistic assessment. Correction: Administration time is a key opportunity to assess the patient’s psychological state, reinforce education, and build a supportive relationship that improves overall care adherence.

Summary

• Safety First: Rigorous adherence to safe handling protocols with PPE and meticulous verifying the treatment plan are the non-negotiable foundations of chemotherapy administration.
• Vigilant Administration: Careful venous access management and constant monitoring for anaphylaxis and extravasation are critical to preventing acute, serious complications during the infusion.
• Systemic Surveillance: Proactive assessing for myelosuppression and proactive managing nausea with antiemetic regimens are essential for managing the expected toxicities of treatment.
• Empowering the Patient: Effective educating patients about neutropenic precautions and implementing infection prevention strategies are what enable safe recovery during the immunocompromised period at home.